1-2 of 2
Bruno Poirier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate

Available to Purchase
Mikaël Croyal, Thi-Thu-Trang Tran, Rose Hélène Blanchard, Jean-Christophe Le Bail, Elise F. Villard, Bruno Poirier, Audrey Aguesse, Stéphanie Billon-Crossouard, Stéphane Ramin-Mangata, Valentin Blanchard, Brice Nativel, Kévin Chemello, Ilya Khantalin, Aurélie Thedrez, Philip Janiak, Michel Krempf, Christophe Boixel, Gilles Lambert, Etienne Guillot
Journal: Clinical Science
Clin Sci (Lond) (2018) 132 (10): 1075–1083.
https://doi.org/10.1042/CS20180040
Published: 31 May 2018
View articletitled, PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate
Open the PDF for PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate in another window
Includes: Supplementary data
Articles

The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies

Available to Purchase
Gilles Lambert, Aurélie Thedrez, Mikaël Croyal, Stéphane Ramin-Mangata, David Couret, Nicolas Diotel, Estelle Nobécourt-Dupuy, Michel Krempf, Jean Christophe LeBail, Bruno Poirier, Jorg Blankenstein, Elise F. Villard, Etienne Guillot
Journal: Clinical Science
Clin Sci (Lond) (2017) 131 (4): 261–268.
https://doi.org/10.1042/CS20160403
Published: 20 January 2017
View articletitled, The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies
Open the PDF for The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies in another window